The Canine Genome: Discoveries, Applications, and Future Potential
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Issue 53 • Fall/Winter 2015 Check out Our Fresh Newsletter Design!
AKC Canine Health Foundation Issue 53 • Fall/Winter 2015 THIS ISSUE AT A GLANCE Dr. Douglas Thamm Receives Asa Mays, DVM Award ............3 CHF Welcomes New CSO .........5 CHF & VetVine Team Up for Webinar Series ..........................6 Distinguished Research Partners to be Honored ........................... 7 2015 National Parent Club Canine Health Conference Recap ..........................................8 Labrador Retriever Club, Inc., to Receive President’s Award ....10 Cold Weather Canine Care ...10 Your Impact: Spontaneous Cancer in Dogs ........................13 Check out our fresh newsletter design! © Copyright 2015 AKC Canine Health Foundation. All rights reserved. Dear Canine Health Supporter: This year, we celebrate the 20th anniversary of the AKC Canine Health Foundation (CHF), a milestone that would not be possible without your commitment to the health of all dogs. Thanks to you, the dogs we love benefit from advances in veterinary medicine, receiving better treatment options and more accurate diagnoses for both common and complex health issues. From laying the groundwork that mapped the canine genome, to awarding grants that eventually led to genetic tests for conditions like Exercise-Induced Collapse and Von Willebrand’s Disease; from working collaboratively with researchers to bring about better understanding and more effective treatments for diseases like cancer, epilepsy and bloat, to being on the forefront of new, promising breakthroughs like stem cell research/regenerative medicine, anti-viral therapy and personalized medicine, your support of CHF has made these breakthroughs possible. As we look toward the future, your gift to CHF is as important as ever. By donating and continuing your commitment to canine health, you help build on the important scientific advances in veterinary medicine and biomedical science, impacting future generations of dogs. -
Canine Breed Predisposition to Cancer
Canine Breed Predisposition to Cancer 1Amalia Saladrigas, 1Adrienne Thom, 2Amanda Koehne, DVM 1Stanford University (Class of 2016), 2Cancer Biology Program, Stanford School of Medicine Introduction Osteosarcoma: large breeds Lymphoma: Golden Retriever Particularly now that pets are living longer, cancer has become a leading 1 cause of death in dogs. Cancer can affect all breeds of dogs, but there are General Information: General Information: some breeds that appear to be at higher risk to certain types of cancer. • Most common primary bone tumor in dogs • Most common tumor of the hematopoietic system in dogs Given the similarities between many human and canine cancers, the domestic • The mean age is 7 years7 • Classification of canine lymphomas follows a similar classification 2 13 dog has been used as a model of spontaneous neoplasia. • It occurs in large and giant breed dogs: Doberman, German Shepherd, Golden scheme to that used for humans Retriever, Great Dane, Irish Setter, Rottweiler and Saint Bernard8 • Golden Retrievers are predisposed • Higher incidence in middle-aged dogs (6-7 years)14 Histiocytic Sarcoma: Bernese Clinical Manifestation: Mountain Dog • Occurs in the metaphysis of long bones, similar to disease in humans Clinical Manifestation: • Most common in proximal humerus, distal femur, and proximal tibia • Clinical signs are highly variable and reflect the organs involved General Information: • Metastasis usually to lungs and other bones • Lymphadenopathy, anorexia, and lethargy are common • Mean age of onset is 6.5 years -
2013 Trainee Institution Lab/Research Group Division Of
2014 Trainee Institution Lab/Research Group Division of Basic Sciences Shannon Barbour University of California, Santa Cruz Harmit Malik, PhD Sarah Debs Whitman College Cecilia Moens, PhD Alec Heckert University of Washington Jesse Bloom, PhD Lauren Hillers Hope College Carissa Perez Olsen, PhD Heather Johns Whitman College Robert Bradley, PhD Chris Large University of Puget Sound Harmit Malik, PhD Division of Clinical Research Linda Dao University of Texas at Arlington Edus (Hootie) Warren, MD, PhD Meselle Jeff-Eke University of Chicago Marie Bleakley, MD, PhD, M.Msc Danielle Oliver Hampton University Cameron Turtle, MD, PhD Maya Rosenfield University of Washington James (Jim) Olson, MD, PhD Derek Wong University of Chicago John Pagel, MD, PhD Division of Human Biology Micah Atwood Northwest University Patrick Paddison, PhD Joshua Messer University of Wyoming Denise Galloway, PhD Emma O'Melia Clark University Catherine (Katie) Peichel, PhD Ethan Paddock Northern Arizona University Julie Overbaugh, PhD ± Monica Salazar New Mexico State University Peggy Porter, MD Sophia Stone Mary Baldwin College Stephen Tapscott, MD, PhD Connor Wagner New Mexico State University Nina Salama, PhD Bailey Wooldridge University of Hawaii at Hilo Adam Geballe, MD Division of Public Health Sciences Meghan Gerry New Mexico State University Kerryn Reding, PhD, MPH Riley Hughes Yale University Johanna Lampe, PhD, RD ± Mayra Lovas New Mexico State University Linda Ko, PhD Shirley Beresford, PhD / Lauren Mercer New Mexico State University Beti Thompson, PhD ± Swati -
Analysis of Inherited and Somatic Variants to Decipher Canine Complex Traits
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1454 Analysis of inherited and somatic variants to decipher canine complex traits KATE MEGQUIER ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6206 ISBN 978-91-513-0310-9 UPPSALA urn:nbn:se:uu:diva-347165 2018 Dissertation presented at Uppsala University to be publicly examined in B:22, BMC, Husargatan 3, Uppsala, Monday, 21 May 2018 at 13:15 for the degree of Doctor of Philosophy (Faculty of Medicine). The examination will be conducted in English. Faculty examiner: David Sargan (University of Cambridge). Abstract Megquier, K. 2018. Analysis of inherited and somatic variants to decipher canine complex traits. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1454. 67 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-0310-9. This thesis presents several investigations of the dog as a model for complex diseases, focusing on cancers and the effect of genetic risk factors on clinical presentation. In Papers I and II, we performed genome-wide association studies (GWAS) to identify germline risk factors predisposing US golden retrievers to hemangiosarcoma (HSA) and B- cell lymphoma (BLSA). Paper I identified two loci predisposing to both HSA and BLSA, approximately 4 megabases (Mb) apart on chromosome 5. Carrying the risk haplotype at these loci was associated with separate changes in gene expression, both relating to T-cell activation and proliferation. Paper II followed up on the HSA GWAS by performing a meta-analysis with additional cases and controls. This confirmed three previously reported GWAS loci for HSA and revealed three new loci, the most significant on chromosome 18. -
Cancer in Dogs
Cancer in Dogs Canine Cancer Facts FACT: Cancer is the leading cause of non-accidental death in dogs. FACT: Lymphoma is the leading cancer diagnosed in dogs. FACT: Nearly 50% of pets over the age of 10 will develop some type of cancer. FACT: The increasing incidence of cancer in dogs is due to longer life spans. What is cancer? Cancer is a single word that encompasses many different types of diseases. Each of these diseases is attributed to the purposeless and uncontrolled growth of cells on or within the body. They are either localized to one part of the body as a visible mass (tumor) or spread throughout (metastasis). Cancer can develop in or from any tissue in the body. Cancer is common in the dog or cat and the rate increases with age. Dogs get cancer at roughly the same rate as humans, while cats get fewer cancers. In one survey, cancer accounted for almost half the deaths of those pets over 10 years of age. There are many different types of cancer, each type named according to the tissue (or part of the body) that it originated. Some cancers have the ability to metastasize (spread) to other parts of the body. Other terms for cancer are malignancy and neoplasia. What causes canine cancer? No one seems to know for sure what causes cancer in our furry friends. Some theories include pesticides, preservatives and fillers used in dog foods; second hand smoke; vaccinations; chronic ehrlichiosis etc. Unfortunately, these are only theories, and have yet to be proven. Since the cause of cancer is not known, prevention is difficult. -
Advertising (PDF)
The power you need. Now at a price you’ll love. Infinium® Genotyping and CNV. Power your research with industry-leading quality and content from Illumina. Discover the fastest way to a successful study at a price lower than you ever imagined: 4 Power your study with the industry’s best genomic coverage and the only product with 1 million SNPs for CNV analysis. 4 Publish faster by using the products that power the most publications for whole-genome association studies. 4 Increase study power by accessing iControlDB, Illumina’s control database. 4 Leverage the power and speed of multi-sample whole-genome genotyping products and custom iSelect™ BeadChips. Join the growing Illumina Community today: www.illumina.com/infinium By Andrew Read and Dian Donnai, University of Manchester, UK “Conceptually brilliant!” David N. Cooper, Professor of Human Molecular Genetics, Cardiff University, UK ritten for students, genetic counselors and clinical geneticists, New Clinical Genetics provides W the reader with a concise summary of post-genomic human genetics and guidance as to how our current understanding can be utilized in clinical practice. The authors have taken an integrated case-based approach to the subject. Realistic case scenarios are used throughout the text so that readers can gain a practical understanding of clinical cases, their diagnoses and treatment options. The book is based on the requirements of the ASHG Medical School Core Curriculum which states that “every physician who practices in the 21st century must have an in-depth knowledge of the principles of human genetics and their application to a wide variety of clinical problems.” For details of how the book covers the core curriculum, please visit www.scionpublishing.com/newclinicalgenetics With self-assessment questions, separate boxes containing diagnostic methods and approaches to common diseases, and over 300 clinical photograph and figures, the book is presented in a user-friendly manner to aid understanding. -
Society for Developmental Biology 71St Annual Meeting
Developmental Biology 368 (2012) 140–163 Contents lists available at SciVerse ScienceDirect Developmental Biology journal homepage: www.elsevier.com/locate/developmentalbiology Society for Developmental Biology 71st Annual Meeting Guest Society: Sociedad Espan˜ola de Biologia del Desarrollo Hilton Montreal Bonaventure Hotel, Montreal, Canada July 19–23, 2012 PROGRAM Program Committee: Mike Levine (Chair, SDB President), Marie Anne Felix, Richard Harland, Maria Leptin, Janet Rossant, Miltos Tsiantis Local Organizers: Loydie Jerome-Majewska, Jacques Drouin, Paul Lasko Notice: Only the meeting program will be published in this issue of Developmental Biology. The program and complete abstracts, including late abstracts and author index, will be posted on the meeting website, available to all, no subscription or registration required. URL: http://www.sdbonline.org/2012/abstracts.htm y—SEBD-sponsored speakers italics—program abstract number Wednesday, July 18 11 am–9 pm SDB 4th Boot Camp for New Faculty at McGill University, Department of Biology. Co-Organizers: Mary Montgomery (Macalester) and Aimee Ryan (McGill) Thursday, July 19 8 am–2 pm SDB 4th Boot Camp for New Faculty (continuation) 1 pm–6 pm Meeting Registration Exhibits and Poster Session I set-up Fontaine 6:00 pm Welcome and Opening Remarks Mike Levine (SDB President) and Angela Nieto (SEBD President) 6:10 pm–8 pm Presidential Symposium Ballroom Sponsored by Mutant Mouse Resource Centers Montreal Chair: Mike Levine (UC Berkeley) 6:10 pm Nicole King (UC Berkeley). Bacterial regulation of a developmental switch in choanoflagellates 6:45 pm Andy McMahon (Harvard). The role of chromatin and gene regulatory networks in Shh-mediated neural patterning 7:20 pm Elaine Ostrander (NIH). -
Mast Cell Tumors Phyllis C Glawe DVM MS Diplomate ACVIM, Oncology
Canine Mast Cell Tumors Phyllis C Glawe DVM MS Diplomate ACVIM, Oncology What is a Mast Cell Tumor? Mast Cell Tumors (MCTs) are one of the most common malignant skin tumors in dogs. Mast cells are the cells that normally are associated with allergy responses, such as the swelling and redness that occur with insect stings. In dogs, mast cell tumors typically are located in the skin of the trunk and peripheral limbs. The masses are typically solitary, reddened in color, hairless and occur in middle age/older dogs. They can be itchy and occasionally can present with ulceration on the skin surface. These tumors are malignant due to their tendency to invade deeply into the surrounding tissue and occasionally spread to other organs, such as the lymph nodes, liver and spleen. One of the more interesting features of this cancer is its behavior: MCTs may grow and shrink rapidly due to inflammation caused by mast cells occasional release of histamine and other vasoactive chemicals. How is the Diagnosis Made? The clinical appearance of MCTs can vary, however the tumors are typically relatively straightforward to diagnose with a fine needle aspiration cytology. A biopsy of tissue can also be performed to obtain the diagnosis, if cytology is not definitive. Special stains can be applied to the tissue biopsy sample to identify the cancer cells if necessary. What is meant by “Grade of the Mast cell tumor” and why is it important? “Grade” of the mast cell tumor refers to characteristics of the cancer cells noted within the tissue biopsy specimen. -
Canine Oral Malignant Melanoma Adam C
Volume 58 | Issue 2 Article 12 1996 Canine Oral Malignant Melanoma Adam C. Eiler Iowa State University Kimberly R. Cox Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/iowastate_veterinarian Part of the Neoplasms Commons, and the Small or Companion Animal Medicine Commons Recommended Citation Eiler, Adam C. and Cox, Kimberly R. (1996) "Canine Oral Malignant Melanoma," Iowa State University Veterinarian: Vol. 58 : Iss. 2 , Article 12. Available at: https://lib.dr.iastate.edu/iowastate_veterinarian/vol58/iss2/12 This Article is brought to you for free and open access by the Journals at Iowa State University Digital Repository. It has been accepted for inclusion in Iowa State University Veterinarian by an authorized editor of Iowa State University Digital Repository. For more information, please contact [email protected]. Canine Oral Malignant Melanoma Adam C. Eiler, DVM * Kimberly R. Cox, DVM ** Neoplasia is an all too common find Veterinary Diagnostic Laboratory for histo ing in domestic animals. The oropharyngeal logic examination, confirming a diagnosis of cavity is a common site for the development oral malignant melanoma. Surgical clear of tumors , particularly in dogs. One such tu ance at the margins was incomplete. The mor is oral malignant melanoma which owner was notified of the findings and given occurs with some frequency in dogs but is a guarded prognosis for long-term survival rare in cats.! Hence, the following shall fo due to the possibility oflocal recurrence and cus on canine malignant melanoma. distant metastasis. "Capricorn" died three years following the Case Study initial diagnosis of oral malignant mela noma. -
What Have We Learned?
A magazine of people, connections and community for alumni of the OHSU School of Medicine Spring 2021 What Have We Learned? Pandemic reflections p. 10 FROM THE DEAN In this issue ON THE COVER Emerging better “Vaccine,” an illustration by Christa Prentiss, second-year M.D. student. KRISTYNA WENTZ-GRAFF PRING IS ABOUT EMERGING FROM WINTER AND, THIS SPRING, IT’S A B O U T Sharon Anderson, M.D. R ’82 emerging from a year like no other. At OHSU and in the School of Medicine, FEATURE the opportunity to emerge differently is clear. Even as we look forward to seeing each other again on our campuses, we Interconnected are building on what we learned about our capacity for distance learning, 6 Alumni reflect on what they’re learned over the past year. Stelework and telemedicine and how these tools, used appropriately, can serve students, faculty, Above, “Herd Immunity,” an illustration in ink, watercolor employees and patients alike. We are learning from the ways in which school faculty and and acrylic by fourth-year M.D. student Arianna Robin. staff joined others across the university in such areas as wellness and research operations to DEAN Sharon Anderson, M.D. R ’82 I invite you to learn more at marshal our highest expertise and best practices for the benefit of all. And we learned from EXECUTIVE EDITOR www.ohsu.edu/som and contact me at – and frankly wish we could bottle – the incredible creativity, brilliance and esprit de corps Erin Hoover Barnett [email protected]. that students, faculty and staff mustered to not only endure but exceed expectations across MANAGING EDITOR missions amid some of the most difficult months this institution and our community have ever UP FRONT Rachel Shafer known. -
Dog Cancer Can Be Effectively Treated, Allowing Your Dog to Continue a Healthy, Happy Life
WHAT EVERY DOG OWNER SHOULD KNOW ABOUT CANCER Copyright © 2017 Marc Smith DVM & PET | TAO Holistic Pet Products, LLC All Rights Reserved Feel free to email, tweet, blog, and pass this e-book around the web… but please don’t alter any of its contents when you do. Thanks! pettao.com Copyright © 2017 Marc Smith, DVM & PET | TAO Holistic Pet Products, LLC 1 WHAT EVERY DOG OWNER SHOULD KNOW ABOUT CANCER WHAT EVERY DOG OWNER SHOULD KNOW ABOUT CANCER Dogs get cancer just like people do. Because cancer is so common in dogs, owners must be aware of the signs and symptoms of cancer. If discovered early, many types of dog cancer can be effectively treated, allowing your dog to continue a healthy, happy life. Our goal is to share information with you about the different dog cancer symptoms, dog cancer treatments, and different preventative measures readily available. Attentive owners can spot dog cancer symptoms as soon as they appear and seek veterinary help immediately. Often, early identification of cancer marks the difference between life and death. If your dog experiences any of the symptoms described below, you should seek veterinary care as soon as possible. Although these symptoms are not proof of cancer, all are possible signs of cancer. Remember, the earlier cancer is identified, the better. Copyright © 2017 Marc Smith, DVM & PET | TAO Holistic Pet Products, LLC 2 WHAT EVERY DOG OWNER SHOULD KNOW ABOUT CANCER Evidence of Pain Evidence of pain or obvious limping while your dog is walking, running or playing is often a sign of arthritis, joint, or muscle issues in older dogs. -
Linkage Disequilibrium Mapping in Domestic Dog Breeds Narrows the Progressive Rod-Cone Degeneration Interval and Identifies Ance
University of Pennsylvania ScholarlyCommons Departmental Papers (Vet) School of Veterinary Medicine 11-2006 Linkage Disequilibrium Mapping in Domestic Dog Breeds Narrows the Progressive Rod-Cone Degeneration Interval and Identifies Ancestral Disease-Transmitting Chromosome Orly Goldstein Barbara Zangerl University of Pennsylvania, [email protected] Sue Pearce-Kelling Duska J. Sidjanin James W. Kijas See next page for additional authors Follow this and additional works at: https://repository.upenn.edu/vet_papers Part of the Disease Modeling Commons, Eye Diseases Commons, Medical Genetics Commons, Ophthalmology Commons, and the Veterinary Medicine Commons Recommended Citation Goldstein, O., Zangerl, B., Pearce-Kelling, S., Sidjanin, D. J., Kijas, J. W., Felix, J., Acland, G. M., & Aguirre, G. D. (2006). Linkage Disequilibrium Mapping in Domestic Dog Breeds Narrows the Progressive Rod-Cone Degeneration Interval and Identifies Ancestral Disease-Transmitting Chromosome. Genomics, 88 (5), 541-550. http://dx.doi.org/10.1016/j.ygeno.2006.05.013 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/vet_papers/96 For more information, please contact [email protected]. Linkage Disequilibrium Mapping in Domestic Dog Breeds Narrows the Progressive Rod-Cone Degeneration Interval and Identifies Ancestral Disease-Transmitting Chromosome Abstract Canine progressive rod–cone degeneration (prcd) is a retinal disease previously mapped to a broad, gene-rich centromeric region of canine chromosome 9. As allelic disorders are present in multiple breeds, we used linkage disequilibrium (LD) to narrow the ∼6.4-Mb interval candidate region. Multiple dog breeds, each representing genetically isolated populations, were typed for SNPs and other polymorphisms identified from BACs. The candidate region was initially localized to a 1.5-Mb zero recombination interval between growth factor receptor-bound protein 2 (GRB2) and SEC14-like 1 (SEC14L).